Koers Bud Genius, Inc. Other OTC
Aandelen
RIGH
US76657X1110
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | 0,04 0,04 | Marktkapitalisatie | 11,25K 10,39K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | - 0 | Nettowinst (verlies) 2010 | - 0 | EV/omzet 2009 | - |
Nettoschuld 2009 | 489K 452K | Nettoschuld 2010 | 396K 366K | EV/omzet 2010 | 9.639.795 x |
K/w-verhouding 2009 |
-23,5
x | K/w-verhouding 2010 |
-
| Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 690,57% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+44,48% | 55,07 mld. | |
-0,86% | 41,79 mld. | |
+43,62% | 40,22 mld. | |
-7,59% | 28,17 mld. | |
+12,30% | 26,28 mld. | |
-21,83% | 18,93 mld. | |
+7,15% | 13,03 mld. | |
+29,40% | 12,26 mld. | |
+25,15% | 12,21 mld. |